These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39045700)

  • 1. Psychosocial experience of the Covid-19 crisis among people who use or inject drugs in Algeria: A community-based qualitative study.
    Di Ciaccio M; Boulahdour N; Tadjeddine A; Brouk N; Ouchallal R; Hami N; Bourhaba O; Adami E; Lorente N; Delabre RM; Karkouri M; Rojas Castro D
    J Health Psychol; 2024 Jul; ():13591053241259251. PubMed ID: 39045700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Vaccine Ambivalence Can Lead People Who Inject Drugs to Decline COVID-19 Vaccination and Ways This Can Be Addressed: Qualitative Study.
    Aronson ID; Bennett AS; Ardouin-Guerrier MA; Rivera-Castellar G; Gibson B; Santoscoy S; Vargas-Estrella B
    JMIR Form Res; 2022 Mar; 6(3):e35066. PubMed ID: 35191841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers.
    Anderson NC; Kesten JM; Ayres R; Hickman M; Amlôt R; Michie S; Lorencatto F
    Int J Drug Policy; 2022 Jan; 99():103437. PubMed ID: 34600415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study.
    Scott S; McGowan VJ; Wildman JM; Bidmead E; Hartley J; Mathews C; James B; Sullivan C; Bambra C; Sowden S
    Lancet; 2022 Nov; 400 Suppl 1():S78. PubMed ID: 36930026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
    Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
    Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic.
    Bowles JM; Kolla G; Smith LR; Scheim A; Dodd Z; Werb D
    Drug Alcohol Depend Rep; 2023 Jun; 7():100167. PubMed ID: 37273749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.
    Vasylyeva TI; Smyrnov P; Strathdee S; Friedman SR
    J Int AIDS Soc; 2020 Jul; 23(7):e25583. PubMed ID: 32697423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.
    Strathdee SA; Abramovitz D; Harvey-Vera A; Vera CF; Rangel G; Artamonova I; Chaillon A; Ignacio C; Calderon A; Martin NK; Patterson TL
    PLoS One; 2021; 16(11):e0260286. PubMed ID: 34807963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic.
    Allen ST; Schneider KE; Morris M; Rouhani S; Harris SJ; Saloner B; Sherman SG
    Harm Reduct J; 2023 Feb; 20(1):18. PubMed ID: 36793041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.
    Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM
    Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
    Croxford S; Emanuel E; Ibitoye A; Njoroge J; Edmundson C; Bardsley M; Heinsbroek E; Hope V; Phipps E
    Public Health; 2021 Mar; 192():8-11. PubMed ID: 33601307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual violence from police and HIV risk behaviours among HIV-positive women who inject drugs in St. Petersburg, Russia - a mixed methods study.
    Lunze K; Raj A; Cheng DM; Quinn EK; Lunze FI; Liebschutz JM; Bridden C; Walley AY; Blokhina E; Krupitsky E; Samet JH
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20877. PubMed ID: 27435712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What has changed in the experiences of people with mental health problems during the COVID-19 pandemic: a coproduced, qualitative interview study.
    Shah P; Hardy J; Birken M; Foye U; Rowan Olive R; Nyikavaranda P; Dare C; Stefanidou T; Schlief M; Pearce E; Lyons N; Machin K; Jeynes T; Chipp B; Chhapia A; Barber N; Gillard S; Pitman A; Simpson A; Johnson S; Lloyd-Evans B;
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jun; 57(6):1291-1303. PubMed ID: 35267053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Community-Based Organizations Responded to the Covid-19 Crisis to Maintain HIV Services Among Vulnerable Populations in Burundi, Mauritania, and Lebanon: Qualitative Results From the Multicountry EPIC Program.
    Di Ciaccio M; Bourhaba O; Khoury C; Assi A; Abu Zaki S; Lorente N; Castro Avila J; Niyongabo A; Gakima D; Diouh A; Riegel L; Ben Moussa A; Girard G; Karkouri M; Delabre RM; Rojas Castro D;
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241263686. PubMed ID: 39110012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health service utilisation and access for people who inject drugs during COVID-19.
    Efunnuga H; Higgs P; Walker S; O'Keefe D
    Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "We've got through hard times before: acute mental distress and coping among disadvantaged groups during COVID-19 lockdown in North India - a qualitative study".
    Mathias K; Rawat M; Philip S; Grills N
    Int J Equity Health; 2020 Dec; 19(1):224. PubMed ID: 33334344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.